Every year, more than two thousand acute acoustic trauma occur in France, equally between the military and the civilian environment. Currently, acute acoustic trauma is a pathology with no specific validated treatment, and it is the cause of many handicapping situations. Improving the future of patients requires a better understanding of the neurophysiological mechanisms of noise-induced hearing impairment. They are multiple and pure tone audiometry, the only reference examination, does not allow to differentiate them. Moreover, in the aftermath of acute acoustic trauma, pure tone audiometry tends to improve spontaneously, but this recovery is misleading, as a number of studies in animals have shown that irreversible lesions remain. The hypothesis of this study is that it is possible to identify new entities, specific to the type of cochlear lesions, in order to clarify the diagnosis of acute acoustic trauma. These entities will be identified by the evaluation of noise-induced hearing impairment via a combination of molecular (proteomic and genomic), physiological and behavioral data. These diagnostic details may then be used to improve prevention or therapy.
Study Type
OBSERVATIONAL
Enrollment
500
The hearing test is composed of several examinations: * pure tone audiogram * otoscopy * tympanometry Healthy individuals: The hearing test will be performed at enrollment (Day 0). Patients: The hearing test will be performed at Day 1, Day 3, Day 7 and Day 30.
The participant will have to fill in a questionnaire about his/her previous noise exposure at enrollment (Day 0).
Healthy individuals: Otoacoustic emission will be measured at enrollment (Day 0). Patients: Otoacoustic emission will be measured at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.
Healthy individuals: Electrocochleography will be performed at enrollment (Day 0). Patients: Electrocochleography will be performed at Day 30.
Healthy individuals: Speech audiometry in noise will performed at enrollment (Day 0). Patients: Speech audiometry in noise will performed at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.
Healthy individuals: Multi-frequency impedance will be measured at enrollment (Day 0). Patients: Multi-frequency impedance will be measured at Day 30.
Tinnitus severity will be assessed using a visual analogic scale at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.
Healthy individuals: A blood sample will be collected at enrollment (Day 0). Patients: A blood sample will be collected at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.
102e Antenne Médicale
Angoulême, France
RECRUITING38e Antenne Médicale
Bitche, France
RECRUITINGHôpital d'Instruction des Armées Clermont-Tonnerre
Brest, France
RECRUITINGLaboratoire mobile d'Audition de l'Institut de Recherche Biomédicale des Armées
Brétigny-sur-Orge, France
RECRUITING171e Antenne Médicale
Caylus, France
RECRUITINGHôpital d'Instruction des Armées Percy
Clamart, France
RECRUITING41e Antenne Médicale
Dieuze, France
RECRUITING123e Antenne Médicale
Guer, France
RECRUITINGHôpital d'Instruction des Armées Laveran
Marseille, France
RECRUITING13e Antenne Médicale
Montlhéry, France
RECRUITING...and 4 more locations
Identification of diagnostic biomarkers of hearing impairment in patients suffering from acute acoustic trauma
Machine learning analyses will be performed on the whole collected data to identify diagnostic biomarkers.
Time frame: Through study completion, an average of 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.